Full name : Sorenson Robert C
First name : Robert C
Mail : 1500 East Medical Center Dr., R4038 Kresge Medical Research II, Ann Arbor, MI 48109-0572
Zip Code :
City :
Country : USA
Email :
Phone : (l) 313 764 5197
Fax : (l) 313 763 4450
Website :
Directory :
| Title : Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase\/arylesterase - Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| Author(s) : Sorenson RC , Aviram M , Bisgaier CL , Billecke S , Hsu C , La Du BN |
| Ref : Chemico-Biological Interactions , 119-120 :243 , 1999 |
| Abstract : Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| ESTHER : Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| PubMedSearch : Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| PubMedID: 10421458 |
| Title : On the physiological role(s) of the paraoxonases - La Du_1999_Chem.Biol.Interact_119-120_379 |
| Author(s) : La Du BN , Aviram M , Billecke S , Navab M , Primo-Parmo S , Sorenson RC , Standiford TJ |
| Ref : Chemico-Biological Interactions , 119-120 :379 , 1999 |
| Abstract : La Du_1999_Chem.Biol.Interact_119-120_379 |
| ESTHER : La Du_1999_Chem.Biol.Interact_119-120_379 |
| PubMedSearch : La Du_1999_Chem.Biol.Interact_119-120_379 |
| PubMedID: 10421474 |
| Title : Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase\/arylesterase - Doorn_1999_Chem.Biol.Interact_119-120_235 |
| Author(s) : Doorn JA , Sorenson RC , Billecke SS , Hsu C , La Du BN |
| Ref : Chemico-Biological Interactions , 119-120 :235 , 1999 |
| Abstract : Doorn_1999_Chem.Biol.Interact_119-120_235 |
| ESTHER : Doorn_1999_Chem.Biol.Interact_119-120_235 |
| PubMedSearch : Doorn_1999_Chem.Biol.Interact_119-120_235 |
| PubMedID: 10421457 |
| Title : Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity - Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| Author(s) : Sorenson RC , Bisgaier CL , Aviram M , Hsu C , Billecke S , La Du BN |
| Ref : Arterioscler Thromb Vasc Biol , 19 :2214 , 1999 |
| Abstract : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| ESTHER : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| PubMedSearch : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| PubMedID: 10479665 |
| Title : The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family - Primo-Parmo_1996_Genomics_33_498 |
| Author(s) : Primo-Parmo SL , Sorenson RC , Teiber JF , La Du BN |
| Ref : Genomics , 33 :498 , 1996 |
| Abstract : Primo-Parmo_1996_Genomics_33_498 |
| ESTHER : Primo-Parmo_1996_Genomics_33_498 |
| PubMedSearch : Primo-Parmo_1996_Genomics_33_498 |
| PubMedID: 8661009 |
| Title : Reconsideration of the catalytic center and mechanism of mammalian paraoxonase\/arylesterase - Sorenson_1995_Proc.Natl.Acad.Sci.U.S.A_92_7187 |
| Author(s) : Sorenson RC , Primo-Parmo SL , Kuo CL , Adkins S , Lockridge O , La Du BN |
| Ref : Proc Natl Acad Sci U S A , 92 :7187 , 1995 |
| Abstract : Sorenson_1995_Proc.Natl.Acad.Sci.U.S.A_92_7187 |
| ESTHER : Sorenson_1995_Proc.Natl.Acad.Sci.U.S.A_92_7187 |
| PubMedSearch : Sorenson_1995_Proc.Natl.Acad.Sci.U.S.A_92_7187 |
| PubMedID: 7638166 |
| Title : Mutation His322Asn in human acetylcholinesterase does not alter electrophoretic and catalytic properties of the erythrocyte enzyme - Masson_1994_Blood_83_3003 |
| Author(s) : Masson P , Froment MT , Sorenson RC , Bartels CF , Lockridge O |
| Ref : Blood , 83 :3003 , 1994 |
| Abstract : Masson_1994_Blood_83_3003 |
| ESTHER : Masson_1994_Blood_83_3003 |
| PubMedSearch : Masson_1994_Blood_83_3003 |
| PubMedID: 8180397 |
| Title : Detection of human DNA mutations with nonradioactive, allele-specific oligonucleotide probes - Hajra_1992_Pharmacogenet_2_78 |
| Author(s) : Hajra A , Sorenson RC , La Du BN |
| Ref : Pharmacogenetics , 2 :78 , 1992 |
| Abstract : Hajra_1992_Pharmacogenet_2_78 |
| ESTHER : Hajra_1992_Pharmacogenet_2_78 |
| PubMedSearch : Hajra_1992_Pharmacogenet_2_78 |
| PubMedID: 1302045 |